Evidence map›Paper›PMID 39930921›Full record

ArticleAnimal models and experimental medicine2025

Yunweiling alleviates functional constipation: integrating network pharmacology and experimental study.

Peng Zhang, Wei Li, Weiwen Zheng, Jinwen Liu, Nuonan She, Xia Chen, Weibo Wen

Abstract read
In one paragraph

Article in Animal models and experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Peng ZhangDepartment of General Surgery, The First People's Hospital of Yunnan Province, Kunming, Yunnan, China.
Wei LiDepartment of Spleen and Stomach of Traditional Chinese Medicine, Yunnan Provincial Hospital of Chinese Medicine, Kunming, Yunnan, China.
Weiwen ZhengDepartment of Spleen and Stomach of Traditional Chinese Medicine, Yunnan Provincial Hospital of Chinese Medicine, Kunming, Yunnan, China.
Jinwen LiuDepartment of Spleen and Stomach of Traditional Chinese Medicine, Yunnan Provincial Hospital of Chinese Medicine, Kunming, Yunnan, China.
Nuonan SheDepartment of Spleen and Stomach of Traditional Chinese Medicine, Yunnan Provincial Hospital of Chinese Medicine, Kunming, Yunnan, China.
Xia ChenDepartment of Spleen and Stomach of Traditional Chinese Medicine, Yunnan Provincial Hospital of Chinese Medicine, Kunming, Yunnan, China.ORCID 0000-0001-9626-2352
Weibo WenDepartment of Geriatrics, Yunnan Provincial Hospital of Chinese Medicine, Kunming, Yunnan, China.

Funding

TCM Spleen and Stomach Discipline Leader Project of High-level Talents in Yunnan Province and TCM Joint Project of Yunnan Provincial Science and Technology Department 202101AZ070001-209.
6 · The paper itself

Abstract

backgroundThis study investigated the impacts and mechanisms of yunweiling in the management of Functional Constipation (FC) using network pharmacology and experimental research.

methodsUsing the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP), Genecard, and Online Mendelian Inheritance in Man (OMIM) databases, a potential gene target for yunweiling in treating FC was found. A pharmacological network was built and viewed in Cytoscape. A protein interaction map was created with STRING and Cytoscape. 'clusterProfiler' helped uncover its mechanism. Molecular docking was done with AutoDock Vina. In a constipation mouse model, Western blot was used to assess yunweiling's effectiveness.

resultsTo investigate yunweiling's therapeutic effects on FC, we employed a loperamide-induced constipation model. Successful model establishment was confirmed by first black stool time, reduced stool output, and impaired gastrointestinal motility. Yunweiling treatment, especially at high and medium doses, significantly alleviated constipation symptoms by reducing first black stool time, increasing stool output, and enhancing gastrointestinal motility. HE staining revealed yunweiling's ability to restore colon tissue structure. Yunweiling modulated the expression of key proteins TP53, P-AKT, P-PI3K, RET, and Rai, implicating its involvement in the PI3K-Akt signaling pathway. Comparative analysis showed yunweiling to be more effective than its individual components (shionone, β-sitosterol, and daucosterol) in improving constipation. The combination of yunweiling with TP53 and PI3K-Akt inhibitors further enhanced its therapeutic effects, suggesting a synergistic mechanism.

conclusionsThe integration of network pharmacology and experimental investigations indicated the effectiveness of yunweiling in managing FC, offering essential theoretical support for clinical application.

Indexed as

ConstipationDrugs, Chinese HerbalNetwork PharmacologyAnimalsDisease Models, AnimalGastrointestinal MotilityLoperamideMaleMedicine, Chinese TraditionalMiceMolecular Docking SimulationSignal TransductionDrugs, Chinese HerbalLoperamidefunctional constipationmouse modelnetwork pharmacologyyunweiling

Identifiers

PMID39930921
PMCPMC12431576

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.